NCT03565705

Brief Summary

Retrospective analysis to assess the impact of spinal anesthesia on peri-operative opioid consumption during open abdominal prostatectomy. The authors compare the group that had spinal anesthesia in combination with propofol sedation and a laryngeal mask to the second group that underwent the same procedure in general anesthesia with tracheal intubation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
636

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

April 24, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 21, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 14, 2018

Completed
Last Updated

January 28, 2019

Status Verified

January 1, 2019

Enrollment Period

4 months

First QC Date

April 24, 2018

Last Update Submit

January 25, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post-operative opioid consumption

    Consumption of piritramid \[mg\] in PACU.

    1 day

Secondary Outcomes (4)

  • Intra-operative opioid consumption

    1 day

  • Pain maximum

    1 day

  • Postoperative recovery time

    1 day

  • PONV/Shivering

    1 day

Study Arms (2)

Spinal anesthesia with propofol sedation

Patients receive spinal anesthesia for analgesia to undergo open abdominal prostatectomy. Ventilation is secured via a laryngeal mask under propofol sedation and no muscular blocking is necessary.

Procedure: Open abdominal prostatectomy

General anesthesia

General anesthesia is conducted with a combination of intravenous opioid (sufentanil) and neuromuscular blocking agent for open abdominal prostatectomy. Patients receive an induction bolus of propofol, undergo tracheal intubation and maintenance of sedation by sevoflurane.

Procedure: Open abdominal prostatectomy

Interventions

Patients undergo standardized open abdominal prostatectomy.

General anesthesiaSpinal anesthesia with propofol sedation

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We aim to include patients that are scheduled for elective, radical open abdominal prostatectomy. Thus only male patients of 18 years or older will participate. Patients with chronic pain therapy (e.g. out-of-hospital opioid therapy) will be excluded from the study.

You may qualify if:

  • elective, radical abdominal prostatectomy
  • \>18 years

You may not qualify if:

  • chronic pain therapy (e.g. out-of-hospital opioid therapy)
  • laparoscopic approach

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology; Center of Anesthesiology and Intensive Care Medicine, Hamburg Eppendorf University Medical Center

Hamburg, 20246, Germany

Location

Related Publications (1)

  • Funcke S, Schick-Bengardt X, Pinnschmidt HO, Beyer B, Fischer M, Kahl U, Nitzschke R. The impact of spinal anaesthesia on perioperative opioid consumption, postoperative pain and oncological outcome in radical retropubic prostatectomy-a retrospective before-and-after effectiveness study. Perioper Med (Lond). 2022 Oct 3;11(1):49. doi: 10.1186/s13741-022-00281-0.

MeSH Terms

Conditions

Pain, PostoperativeAgnosia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Officials

  • Rainer Nitzschke, MD

    Universitätsklinikum Hamburg-Eppendorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2018

First Posted

June 21, 2018

Study Start

April 24, 2018

Primary Completion

August 8, 2018

Study Completion

October 14, 2018

Last Updated

January 28, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations